ALFA Finder| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 0.1 | 0.0 | 0.2 |
| Total income | 0.1 | 0.0 | 0.2 |
| Profit before exceptional items & tax | 0.1 | 0.0 | 0.1 |
| Profit before tax | 0.1 | 0.0 | 0.1 |
| Net profit | 0.1 | 0.0 | 0.1 |
| Operating margin | 100.0% | 0.0% | 50.0% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +0.00% |
|---|---|
| Revenue, year on year | -50.00% |
BSE results filing, NSE: AMARDEE. Figures extracted from the filing.
Amerise Biosciences Ltd: key numbers
- Share price
- ₹0.87
- Market cap
- ₹5.75 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹0.02 Cr
- P/E (TTM)
- -84.4×Sector 29.0×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amerise Biosciences Ltd
All →Amerise Biosciences Capital Structure Change
Snehjeev Ventures and persons acting in concert acquired 18,342 Amerise Biosciences shares in the open market on 28 Oct 2026. Their holding crossed 13%, reaching 13.02%.
Amerise Biosciences Board Meeting Date
Amerise Biosciences will hold a board meeting on 30 October 2026 to consider Q2 and H1 FY27 unaudited results. This is an advance notice of a future meeting with no financial figures disclosed.
Amerise Biosciences Other Announcement
Amerise Biosciences Ltd filed its quarterly shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI regulatory requirements.
Amerise Biosciences Annual General Meeting
Amerise Biosciences Limited conducted its 41st Annual General Meeting on September 24, 2026. Shareholders approved financial statements and the appointment of a new Wholetime Director and CFO.
Amerise Biosciences Annual Report
Amerise Biosciences has submitted its Annual Report for the financial year 2024-25. The company scheduled its 41st Annual General Meeting for September 24, 2026.
Amerise Biosciences Annual General Meeting
Amerise Biosciences Ltd has submitted the notice for its 41st Annual General Meeting, scheduled to be held on September 24, 2026.